Literature DB >> 7678778

Morphological and functional properties of TM preneoplastic mammary outgrowths.

D Medina1, F S Kittrell, Y J Liu, M Schwartz.   

Abstract

The TM series of preneoplastic mammary outgrowth lines was derived from the transplantation of the FSK mammary cell lines into the cleared mammary fat pads of syngeneic female BALB/c mice. The tumor-producing capabilities of the 6 TM outgrowth lines varied from high (TM2, -4, -6) to low (TM9, -10) to nil (TM3). Outgrowth lines 2, 4, and 6 each segregated into sublines of high and low tumor potential. The majority of the outgrowth lines exhibited a moderate to dense alveolar hyperplasia typical of mouse mammary hyperplasias. The exceptions to this picture were lines TM2H and TM10 which exhibited a unique ductular morphology. The ductular morphology was not correlated with tumor potential of the outgrowth lines but was correlated with the expression of K6 and K14 keratins in luminal epithelial cells. In an examination of the growth and hormonal responsiveness properties of the TM outgrowth lines, the TM3 line stands as distinct from the other lines and from any other lines previously characterized in BALB/c mice. The TM3 line grew very slowly and failed to fill the fat pad by 12 months of age. At 12 months of age, the alveolar hyperplasia had regressed so that only bare ducts were present. The TM3 outgrowth was ovarian hormone dependent for growth and alveolar differentiation. TM3 outgrowth represents a minimally deviated mammary hyperplasia which has acquired the immortal phenotype but not the other phenotypic characteristics of mammary preneoplasias. This outgrowth line will be useful for examining the essential molecular changes important for the preneoplastic state, some of which are reported in an accompanying paper (D. Medina et al., Cancer Res., 53: 668-674, 1993).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678778

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Transfection of mouse mammary epithelial cells.

Authors:  C A Hollmann; D Medina; J S Butel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

2.  Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis.

Authors:  T K Bera; R C Guzman; S Miyamoto; D K Panda; M Sasaki; K Hanyu; J Enami; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 3.  Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential.

Authors:  Airo Tsubura; Katsuhiko Yoshizawa; Norihisa Uehara; Takashi Yuri; Yoichiro Matsuoka
Journal:  Med Mol Morphol       Date:  2007-03-29       Impact factor: 2.309

Review 4.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 5.  Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.

Authors:  Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-29       Impact factor: 2.673

Review 6.  The preneoplastic phenotype in murine mammary tumorigenesis.

Authors:  D Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

7.  Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential.

Authors:  Frances S Kittrell; Martha Z Carletti; Sofia Kerbawy; Jessica Heestand; Wa Xian; Mei Zhang; Heather L Lamarca; Arnoud Sonnenberg; Jeffrey M Rosen; Daniel Medina; Fariba Behbod
Journal:  Breast Cancer Res       Date:  2011-04-05       Impact factor: 6.466

8.  Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors.

Authors:  Brigitte Blackman; Tanya Russell; Steven K Nordeen; Daniel Medina; Margaret C Neville
Journal:  Breast Cancer Res       Date:  2005-01-17       Impact factor: 6.466

9.  Re-evaluation of mammary stem cell biology based on in vivo transplantation.

Authors:  Gilbert H Smith; Daniel Medina
Journal:  Breast Cancer Res       Date:  2008-02-25       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.